Adults aged ≥65 years are strongly recommended to receive either high-dose or adjuvanted influenza vaccine every year
Adults aged ≥65 years are strongly recommended to receive an annual dose of either of 2 enhanced trivalent influenza vaccines (TIVs):
- a high-dose influenza vaccine (Fluzone High-Dose)
- an adjuvanted influenza vaccine (Fluad)
Influenza-associated mortality rates are highest among adults aged ≥65 years.4 Vaccinating elderly people reduces hospitalisations from influenza and pneumonia, and all-cause mortality.8
The high-dose (Fluzone High-Dose) and adjuvanted (Fluad) TIVs are recommended in preference to quadrivalent influenza vaccines for adults aged ≥65 years. However, neither of these 2 TIVs is preferred over the other. See also Vaccine information.
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/adults-aged-65-years-are-strongly-recommended-to-receive-either-high-dose-or.